REGENVET
LIVE

Serial Number

97431513

Owner

RegenLab USA LLC

Attorney

Lindsay Kaplan

Filing Date

May 27, 2022

Add to watchlist:

No watchlists yet
View on USPTO

REGENVET Trademark

Serial Number: 97431513

REGENVET is a trademark filed by RegenLab USA LLC on May 27, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

RegenLab USA LLC (60 trademarks)

95 Greene Street

Entity Type: 16

Trademark Details

Filing Date

May 27, 2022

Registration Date

Not Registered

Published for Opposition

August 5, 2025

Goods & Services

Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontium growth, and bone, organ or tissue regeneration; Adjuvants for medical purposes; Biological preparations for medical purposes, namely, platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid or any combinations thereof; pharmaceutical skin lotions; Tissues impregnated with pharmaceutical lotions for skin conditions, and for promoting cellular regeneration, tissue adhesion, wound healing, and regeneration of bone, organ or tissue; Medical dressings; Surgical cloth tissues; Medicated skin care preparations; Pharmaceutical products, preparations and substances for the treatment of damaged skin and tissue; Medical preparations for cleaning the skin; Cells for medical or clinical use

Centrifuges for medical purposes

Surgical, apparatus and instruments for medical, dental, and veterinary use; Suture materials; Medical kits comprised of surgical and medical instruments and devices, namely, blood collection tubes, drug administration tubes, syringes, needles, anticoagulants, coagulation activators in the nature of autologous thrombin serum, hyaluronic acid for pharmaceutical purposes and chitosan chemicals, gels for separating blood components, all for use in the preparation of platelet concentrate, platelet rich plasma, platelet poor plasma, fibrin gel, platelet rich fibrin, cell extracts, cell concentrates, stem cells, hyaluronic acid, chitosan or any combinations thereof; Kits for tissue and cellular regeneration, rejuvenation, healing and repair, and regenerative medicine, and for the isolation and application of platelets and cells, comprised of receptacles in the nature of blood collection tubes, drug administration tubes, sterile vials, sterile jars for holding platelet-rich plasma preparations for topical medical use, not of paper, medical syringes, needles for medical use, and disposable medical sterilization pouches; Cases fitted for medical instruments; Receptacles for applying medicines, namely, medical containers, cannula, syringes, tubes, infusion and injection devices for administering drugs, platelet rich plasma, hyaluronic acid, and hydrogels; Medical tubing for administering drugs, platelet-rich plasma, hyaluronic acid and hydrogels; Syringes for medical use; Containers specially adapted for storing tissue and biological samples for medical purposes; Surgical instruments for identifying, separating, or removing biological tissue; Medical apparatus used for taking blood; Medical apparatus for separating or filtering blood components; Medical instruments used for filtering blood and blood components; Medical apparatus for introducing pharmaceutical preparations into the human body; Surgical and medical instruments for use with biological tissues; Medical apparatus and instruments for the preparation of platelet concentrate;

Veterinary services; Veterinary services, namely, hygiene and beauty treatments; Veterinary specialty services providing advanced medical, diagnostic or surgical services for animals

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 28, 2026 EXRA
SOU EXTENSION 1 GRANTED
Mar 27, 2026 EX1G
SOU EXTENSION 1 FILED
Mar 27, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 27, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 30, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 30, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 26, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 26, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 26, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 26, 2025 CNEA
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Jun 17, 2025 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Jun 17, 2025 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Jun 17, 2025 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 9, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 9, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 9, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 11, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 11, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 11, 2025 CNFR
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 10, 2025 RCCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2024 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 1, 2024 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 6, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 6, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jul 6, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2023 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 15, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 10, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 10, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 10, 2023 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2022 NWOS
NEW APPLICATION ENTERED
May 31, 2022 NWAP